"Journal of Diabetes" will be officially converted into an open access journal in 2022

"Journal of Diabetes" will be officially converted into an open access journal in 2022

"Journal of Diabetes" will be officially converted into an open access journal in 2022 "Journal of Diabetes" will be officially converted into an open access journal in 2022

The Wiley medical journal Journal of Diabetes will be officially converted into an Open Access journal in 2022, and only OA submissions will be accepted from now on

Journal of Diabetes

The Journal of Diabetes (JDB), a medical journal owned by Wiley , will officially switch to Open Access for publication in the first issue of 2022.
From September 15, 2021, JDB will only accept OA submissions and will charge an article publication fee (APC) based on the type of article.
)
.

Once published, all OA articles can be read and downloaded for free worldwide, which greatly increases the dissemination and citation of the paper

The Journal of Diabetes (JDB), a medical journal owned by Wiley , will officially switch to Open Access for publication in the first issue of 2022.

Brief introduction of the journal:

Brief introduction of the journal: Brief introduction of the journal:

Journal of Diabetes (JDB) is a high-quality publication jointly published by Wiley and Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine.
It is dedicated to the research, treatment and education of diabetes.
In terms of disease, management and prevention, including the molecular, biochemical, and physiological aspects of diabetes, exchanges and cooperation between East and West scientific researchers and practitioners will be carried out
.

JDB was launched in 2009, and this year marks its 13th anniversary, with an impact factor of 4.

Journal of Diabetes Journal of Diabetes

Journal of Diabetes wholeheartedly welcomes clinicians, researchers and industry professionals to read the contents of the journal and actively contribute to the journal
.

Journal of Diabetes Journal of Diabetes

Submission address: http://mc.
manuscriptcentral.
com/jdb

http://mc.
manuscriptcentral.
com/jdb http://mc.
manuscriptcentral.
com/jdb

Journal homepage: https://onlinelibrary.
wiley.
com/journal/17530407

https://onlinelibrary.
wiley.
com/journal/17530407 https://onlinelibrary.
wiley.
com/journal/17530407

Editor-in-chief's message:

Editor-in-chief's message: Editor-in-chief's message:

Zachary Bloomgarden

Zachary Bloomgarden Zachary Bloomgarden

Guang Ning

Guang Ning Guang Ning

According to the latest data released by Clarivate Analytics on June 30, 2021, the 2020 Impact Factor of Journal of Diabetes has risen to 4.
006
.

The impact factor is calculated by dividing the total number of citations of papers published in 2018 and 2019 in 2020 by the total number of papers published in the previous two years.

Journal of Diabetes

The editor-in-chief and associate editors of the journal are very interested in the development of the Open Access publishing model in the medical field.
We hope that the research and reviews of this journal can help all people who are engaged in diabetes research and treatment
.

Like many other journals in this field, we will move to open access from the first issue in 2022

We will switch to open access from the first phase of 2022

On the 13th year of the establishment of the journal, we invite you, readers and collaborators of the journal, to continue to participate in the cooperation and exchanges with researchers from all over the world, focusing on the epidemiology, etiology, pathogenesis, complications, and management of diabetes And prevention, including the molecular, biochemical, and physiological aspects of diabetes to carry out East-West dialogue

Professor Zachary T.
Bloomgarden

Professor Zachary T.
Bloomgarden

He is a clinical professor at the Icahn School of Medicine at Mount Sinai, New York, USA.
He enjoys an international reputation in the field of diabetes research and has published more than 500 papers
.

Co-editor of Journal of Diabetes

Journal of Diabetes Commissioner Diabetes Care

Guang Ning Fellow

Guang Ning Fellow Fellow

Academician of Chinese Academy of Engineering ; Tenured Professor of Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine ; Dean of Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine ; President of Shandong First Medical University; Director of National Metabolic Disease Clinical Medicine Research Center
.

Former Chinese Medical Association Endocrine and Metabolic Physician club president (2013-2019); director of the Chinese Medical Association Endocrinology Branch Committee (2008-2012)

Academician and Dean Member Journal of Diabetes Special Appointment

Wiley is a global leader in the field of scientific research and education, stimulating people's potential by promoting discovery, empowering education and shaping talents
.

For more than 200 years, Wiley has promoted the development of a global knowledge ecosystem
.
Today, our high-impact content, platforms and services help researchers, learners, institutions and companies achieve their goals in a rapidly changing world
.
Wiley's global headquarters is located in Hoboken, New Jersey, USA.
The company is listed on the New York Stock Exchange under the trading symbols JWa and JWb
.

Welcome to follow Wiley’s official WeChat subscription account, Wiley, and service account, Wiley scientific research services, to learn more about the latest scientific research services and open access to information
.